Core Insights - The incidence of thyroid cancer in China is rapidly increasing, with 466,100 new cases reported in 2024, making it the third most common cancer, particularly affecting younger populations [1][3] - There is a prevalent misconception among the public that thyroid cancer is a "lazy cancer," leading to insufficient follow-up and long-term management [1][3] - Clinical experts emphasize the need to break this misconception and raise awareness about the potential dangers and recurrence risks associated with thyroid cancer [1][3] Incidence and Demographics - In the 15-29 age group, thyroid cancer has the highest number of new cases among all cancers [1] - The 2025 Beijing Health Report indicates that thyroid cancer accounts for 48.8% of all cancer diagnoses during health screenings [1] - The female incidence rate of thyroid cancer is 49.4 per 100,000, with a 20% annual increase since 2000, making it one of the most common cancers among women in China [3] Mortality and Survival Rates - Despite the rising incidence, thyroid cancer has a relatively low mortality rate, with both male and female death rates not ranking in the top ten for cancer-related deaths [3] - The five-year survival rate for thyroid cancer in China is 92.9%, which is lower than the 98%-99% survival rates in the United States [4] Recurrence and Management - The recurrence rate for thyroid cancer can reach 20% after ten years, with high-risk patients experiencing rates exceeding 30% [4] - Experts stress the importance of dynamic assessment and standardized follow-up care to mitigate recurrence risks [4][5] - Patients should undergo stratified risk assessments based on pathology, tumor size, and lymph node involvement to determine follow-up frequency and treatment strategies [5] Treatment and Follow-Up Protocols - The use of recombinant human thyroid-stimulating hormone (rh-TSH) for postoperative dynamic assessment is recommended to improve patient compliance and long-term survival rates [6] - Follow-up schedules should be tailored to individual patient needs, with initial assessments occurring one month post-surgery and subsequent evaluations based on treatment response [6][7] - Patients are advised against self-adjusting medication dosages and should maintain a balanced diet while managing stress levels to reduce recurrence risks [7] Awareness and Education - Establishing a Thyroid Cancer Prevention and Treatment Day is suggested to enhance public awareness and understanding of thyroid cancer management [7]
破除误区：甲状腺癌并非全是“懒癌“，复发风险不容忽视
2 1 Shi Ji Jing Ji Bao Dao·2025-09-21 06:42